Literature DB >> 15015020

Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies.

A Bender, G Jäger, W Scheuerer, B Feddersen, R Kaiser, H-W Pfister.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15015020     DOI： 10.1007/s00415-004-0329-z

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  12 in total

1.  [Fatal outcome of tick-borne encephalitis despite complete active vaccination].

Authors:  S Koppi; P Faé; G Hartmann; R Höftberger; H Holzmann
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

2.  Clinical features of double infection with tick-borne encephalitis and Lyme borreliosis transmitted by tick bite.

Authors:  I Logina; A Krumina; G Karelis; L Elsone; L Viksna; B Rozentale; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-05       Impact factor: 10.154

3.  The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome.

Authors:  Amber R Engel; Alexander A Rumyantsev; Olga A Maximova; James M Speicher; Brian Heiss; Brian R Murphy; Alexander G Pletnev
Journal:  Virology       Date:  2010-07-01       Impact factor: 3.616

4.  Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes.

Authors:  Amber R Engel; Dana N Mitzel; Christopher T Hanson; James B Wolfinbarger; Marshall E Bloom; Alexander G Pletnev
Journal:  Vector Borne Zoonotic Dis       Date:  2010-12-13       Impact factor: 2.133

5.  Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.

Authors:  Peter F Wright; Sharon Ankrah; Susan E Henderson; Anna P Durbin; Jim Speicher; Stephen S Whitehead; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2008-01-04       Impact factor: 3.641

6.  Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system.

Authors:  Martin Palus; Jarmila Vojtíšková; Jiří Salát; Jan Kopecký; Libor Grubhoffer; Marie Lipoldová; Peter Demant; Daniel Růžek
Journal:  J Neuroinflammation       Date:  2013-06-27       Impact factor: 8.322

7.  Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection.

Authors:  Alexander J McAuley; Bevan Sawatsky; Thomas Ksiazek; Maricela Torres; Miša Korva; Stanka Lotrič-Furlan; Tatjana Avšič-Županc; Veronika von Messling; Michael R Holbrook; Alexander N Freiberg; David W C Beasley; Dennis A Bente
Journal:  NPJ Vaccines       Date:  2017-03-13       Impact factor: 7.344

8.  Fatal Outcome of European Tick-borne Encephalitis after Vaccine Failure.

Authors:  Parham Sendi; Cédric Hirzel; Stefan Pfister; Rahel Ackermann-Gäumann; Denis Grandgirard; Ekkehard Hewer; Arto C Nirkko
Journal:  Front Neurol       Date:  2017-04-03       Impact factor: 4.003

9.  Upregulated Intrathecal Expression of VEGF-A and Long Lasting Global Upregulation of Proinflammatory Immune Mediators in Vaccine Breakthrough Tick-Borne Encephalitis.

Authors:  Miša Pavletič; Misa Korva; Nataša Knap; Petra Bogovič; Lara Lusa; Klemen Strle; Mirijam Nahtigal Klevišar; Tomaž Vovko; Janez Tomažič; Stanka Lotrič-Furlan; Franc Strle; Tatjana Avšič-Županc
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

10.  Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals.

Authors:  Pontus Lindblom; Peter Wilhelmsson; Linda Fryland; Andreas Matussek; Mats Haglund; Johanna Sjöwall; Sirkka Vene; Dag Nyman; Pia Forsberg; Per-Eric Lindgren
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.